Zobrazeno 1 - 8
of 8
pro vyhledávání: '"I J Gudmundsdottir"'
Autor:
H O Reynisdottir, M K Kristjansdottir, B A Mogensen, T Gudbjartsson, K A Andersen, M I Sigurdsson, I J Gudmundsdottir
Publikováno v:
European Heart Journal. 43
Introduction Coronary artery bypass surgery (CABG) has been standard treatment for patients with left main coronary artery disease (LMCAD) but percutaneous coronary intervention (PCI) is a good alternative in selected patients. Our purpose was to eva
Autor:
Casanova-Sandoval, Juan1,2 (AUTHOR), Fernández-Rodríguez, Diego1,2 (AUTHOR), Otaegui, Imanol3 (AUTHOR), Gil Jiménez, Teresa4 (AUTHOR), Rodríguez-Esteban, Marcos5 (AUTHOR), Rivera, Kristian1,2 (AUTHOR), Torres-Saura, Francisco6 (AUTHOR), Jiménez Díaz, Víctor7 (AUTHOR), Ocaranza-Sánchez, Raymundo8 (AUTHOR), Peral Disdier, Vicente9 (AUTHOR), Sánchez-Elvira, Guillermo10 (AUTHOR), Worner, Fernando1,2 (AUTHOR)
Publikováno v:
Journal of Interventional Cardiology. 3/31/2021, p1-8. 8p.
Publikováno v:
Advanced Biology; Oct2022, Vol. 6 Issue 10, p1-20, 20p
Autor:
Tunestveit, Merete
Publikováno v:
European Journal of Social Work; Sep2021, Vol. 24 Issue 5, p815-827, 13p
Autor:
Hu, Sheng-Ben, Zou, Qian, Lv, Xin, Zhou, Ruo-Lin, Niu, Xian, Weng, Chen, Chen, Fang, Fan, Ya-Wei, Deng, Ze-Yuan, Li, Jing
Publikováno v:
Food & Function; Jan2020, Vol. 11 Issue 1, p649-661, 13p
Autor:
Dario Buccheri
The Interventional Cardiology World is a basic but exhaustive manual treating the most diffuse tools and techniques on coronary artery disease invasively managed represented by basic coronary angiography, the most recent functional studies, namely fr
Autor:
Stief, Thomas
Thrombin is the main factor of mammalian blood coagulation, a complex system generating fibrin clots that physiologically prevents critical bleeding at local areas of tissue injury. There are many diseases, situations, or drugs that critically alter
Autor:
National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Roundtable on Genomics and Precision Health, Sarah H. Beachy, Steve Olson, Amanda Wagner Gee, Siobhan Addie
The process of discovering and developing a new drug or therapy is extremely costly and time consuming, and recently, it has been estimated that the creation of a new medicine costs on average more than $2 billion and takes 10 years to reach patients